Medicare Enrolled

Dr. Brian Slomovitz, M.D.

Gynecologic Oncology Physician · Fort Lauderdale, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
1600 S ANDREWS AVE STE 101, Fort Lauderdale, FL 33316
9543554345
In practice since 2006 (19 years)
NPI: 1306885512 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Slomovitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Slomovitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Slomovitz

Dr. Brian Slomovitz is a gynecologic oncology physician in Fort Lauderdale, FL, with 19 years in practice. Based on federal Medicare data, Dr. Slomovitz performed 363 Medicare services across 159 unique beneficiaries.

Between the years covered by Open Payments, Dr. Slomovitz received a total of $452,770 from 67 pharmaceutical and/or device companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Slomovitz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 33% volume in FL$ $452,770 industry payments

Medicare Practice Summary

Medicare Utilization ↗
363
Medicare services
Top 33% in FL for gynecologic oncology physician
159
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~19 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)165$116$356
Hospital follow-up visit, high complexity81$104$329
Office visit, established patient (30-39 min)68$77$252
New patient office visit, complex (60-74 min)27$155$552
New patient office visit (45-59 min)22$117$433
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$452,770
Total received (2018-2024)
Avg $64,681/year across 7 years
Top 2% in FL for gynecologic oncology physician
67
Companies
575
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$342,633 (75.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56,498 (12.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$53,640 (11.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$93,446
2023
$89,879
2022
$67,906
2021
$57,034
2020
$39,122
2019
$38,885
2018
$66,498

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Seagen Inc.
$71,219
AstraZeneca Pharmaceuticals LP
$66,317
Merck Sharp & Dohme LLC
$49,361
TESARO, Inc.
$47,746
Incyte Corporation
$22,707
Genmab U.S., Inc.
$18,368
Merck Sharp & Dohme Corporation
$17,707
F. Hoffmann-La Roche AG
$17,415
Karyopharm Therapeutics Inc.
$13,665
GlaxoSmithKline, LLC.
$12,937
Eisai Inc.
$10,995
EISAI INC.
$9,901
Aadi Bioscience, Inc.
$9,874
Novocure GmbH
$7,965
AstraZeneca UK Limited
$7,694
BeiGene USA, Inc.
$7,163
AbbVie Inc.
$6,320
Regeneron Pharmaceuticals, Inc.
$5,966
Clovis Oncology, Inc.
$5,660
Eli Lilly and Company
$4,200
Daiichi Sankyo Inc.
$4,147
AbbVie, Inc.
$3,858
Immunocore Limited
$3,685
Myriad Genetic Laboratories, Inc.
$3,481
Gilead Sciences, Inc.
$3,325
Janssen Products, LP
$3,207
BioNTech SE
$2,454
Novartis Pharmaceuticals Corporation
$2,261
Novocure Inc.
$2,240
PFIZER INC.
$1,987
JAZZ PHARMACEUTICALS INC.
$1,800
Genentech, Inc.
$1,719
ImmunoGen, Inc.
$1,662
Seattle Genetics, Inc.
$1,040
Genentech USA, Inc.
$498
Janssen Biotech, Inc.
$270
Intuitive Surgical, Inc.
$236
AVEO Pharmaceuticals, Inc.
$194
Deciphera Pharmaceuticals Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$122
Foundation Medicine, Inc.
$108
Exelixis Inc.
$108
Pharmacosmos Therapeutics Inc.
$104
Astellas Pharma US Inc
$91
Adaptive Biotechnologies Corporation
$90
ABBVIE INC.
$88
Lilly USA, LLC
$85
Aveo Pharmaceuticals, Inc.
$62
SERVIER PHARMACEUTICALS LLC
$61
G1 Therapeutics, Inc.
$42
Pharmacyclics LLC, an AbbVie Company
$42
TAIHO ONCOLOGY, INC.
$40
Pharmacyclics LLC, An AbbVie Company
$40
Alexion Pharmaceuticals, Inc.
$35
Celgene Corporation
$34
GENZYME CORPORATION
$32
Amgen Inc.
$28
American Regent
$25
Mirati Therapeutics, Inc.
$23
Kyowa Kirin, Inc.
$22
SOBI, INC
$22
EMD Serono, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
Stemline Therapeutics Inc.
$16
RECORDATI_RARE_DISEASES_INC.
$15
Tempus AI, Inc
$14
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 41.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Avastin · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · ELAHERE · ELREXFIO · ENHERTU · EPKINLY · Elahere · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · FRUZAQLA · FYARRO · Fyarro · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LENVIMA · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lucitanib · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYRISK · NINLARO · Non-Covered Product · Nplate · Oncology · Optune · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PRECISETUMOR · Padcev · Phesgo · PreciseTumor · QINLOCK · REBLOZYL · RYBREVANT · Rubraca · SYLVANT · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · XARELTO · XPOVIO · XT CDX · Xtandi · YONDELIS · ZEJULA · ZEPZELCA · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for gynecologic oncology physician in FL.

Equivalent to $124,730 per 100 Medicare services performed
Looking for a gynecologic oncology physician in Fort Lauderdale?
Compare gynecologic oncology physicians in the Fort Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse gynecologic oncology physicians nearby

Geographic Context

Gynecologic Oncology Physicians within 10 mi
21
Per 100K population
1.1
County median income
$74,534
Nearest hospital
BROWARD HEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Slomovitz is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Slomovitz experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Slomovitz performed 165 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Slomovitz receive payments from pharmaceutical companies?
Yes. Dr. Slomovitz received a total of $452,770 from 67 companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Slomovitz's costs compare to other gynecologic oncology physicians in Fort Lauderdale?
Dr. Slomovitz's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Slomovitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →